Gian Paolo F.
- Country
- Italy
- Department
- UOC di Oncoematologia Pediatrica
Research Overview
- Intraclass Safety and Efficacy Evaluation of SGLT2 Inhibitors in Elderly Patients with Type 2 Diabetes: A Phase IV Multicenter Randomized Controlled Trial
- A single-arm, open-label, phase I/II clinical trial of autologous hematopoietic stem and progenitor cells (HSPCs) genetically modified with a lentiviral vector (LVV) encoding for the human programmed death-ligand 1 (hPD-L1) complementary deoxyribonucleic acid (cDNA) for the treatment of patients with type 1 diabetes (T1D) at recent onset and with residual β-cell function (Immunostem)
Data & Insights
Has run more than one trial at 1 of 27 partner sites.
Specializations
Diabetes Management
The investigator specializes in the treatment of Type 2 diabetes mellitus, with particular focus on elderly patient populations. Their research explores innovative therapeutic approaches using SGLT2 inhibitors for diabetic care.
- Glycemic Control Optimization
- Elderly Patient Care
- Diabetes Treatment Safety
Their work encompasses the evaluation of treatment efficacy in achieving individualized HbA1c targets while maintaining patient safety.
Geriatric Medicine
The investigator focuses on age-specific aspects of metabolic disorders management, particularly addressing the unique challenges faced by elderly patients with diabetes.
- Age-Specific Treatment Strategies
- Medication Safety in Elderly
- Quality of Life Assessment
Their research emphasizes pragmatic approaches to diabetes care in the aging population.
Clinical Pharmacology
The investigator studies the therapeutic applications of novel antidiabetic medications, with specific attention to comparative effectiveness between different treatment options.
- Drug Class Comparisons
- Treatment Optimization
- Long-term Outcomes
Their research includes evaluation of medication efficacy and safety profiles in real-world clinical settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.